Casdin Capital, LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.

Quarter-by-quarter ownership
Casdin Capital, LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$122,472,203
+5.4%
1,010,330
-0.5%
13.56%
+33.4%
Q2 2023$116,237,800
-28.8%
1,015,000
-14.3%
10.16%
-24.5%
Q1 2023$163,328,550
-4.1%
1,185,000
-9.9%
13.45%
+1.9%
Q4 2022$170,397,700
+25.8%
1,315,000
+7.3%
13.20%
+48.4%
Q3 2022$135,412,000
+177.9%
1,225,000
+88.5%
8.90%
+115.9%
Q2 2022$48,724,000
-22.0%
650,000
-18.8%
4.12%
+47.0%
Q1 2022$62,496,000
-48.6%
800,000
-40.7%
2.80%
-18.2%
Q4 2021$121,568,000
+19.5%
1,350,000
+22.7%
3.43%
+35.3%
Q3 2021$101,728,000
+47.9%
1,100,000
+24.3%
2.53%
+45.0%
Q2 2021$68,800,000
+67.8%
885,000
+60.9%
1.75%
+43.0%
Q1 2021$40,992,000
-54.6%
550,000
+3.8%
1.22%
-54.4%
Q4 2020$90,360,000
+21.4%
530,0000.0%2.68%
-19.7%
Q3 2020$74,428,000
-12.4%
530,0000.0%3.33%
-33.7%
Q2 2020$84,980,000
+29.7%
530,000
-20.9%
5.03%
-27.7%
Q1 2020$65,539,000
-24.2%
670,0000.0%6.96%
-12.5%
Q4 2019$86,457,000
-99.9%
670,000
-23.9%
7.95%
+15.9%
Q3 2019$66,281,600,000
+30.2%
880,000
+162.7%
6.86%
+43.9%
Q2 2019$50,903,250,000
+139924.9%
335,000
+9.8%
4.76%
+19.3%
Q1 2019$36,353,000
+122.1%
305,000
+103.3%
3.99%
+42.6%
Q4 2018$16,370,000
+153.4%
150,000
+275.0%
2.80%
+256.8%
Q3 2018$6,460,00040,0000.78%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Ikarian Capital, LLC 399,400$35,962,0005.36%
Avoro Capital Advisors LLC 3,125,000$281,406,0004.79%
Varenne Capital Partners 324,661$29,236,0004.34%
Evolutionary Tree Capital Management, LLC 96,695$8,707,0004.18%
Ally Bridge Group (NY) LLC 120,000$10,806,0003.78%
Casdin Capital, LLC 1,350,000$121,568,0003.43%
Ghost Tree Capital, LLC 100,000$9,005,0003.23%
GREAT POINT PARTNERS LLC 145,405$13,094,0002.91%
Camber Capital Management LP 825,000$74,291,0002.55%
Alpha DNA Investment Management LLC 17,522$1,577,0001.00%
View complete list of SAREPTA THERAPEUTICS INC shareholders